From: Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study
Gram neg. (N = 68) | Gram pos. (N = 46) | Virus (N = 62) | Other (N = 5) | ||||
---|---|---|---|---|---|---|---|
E. coli | 29 | CoNS | 26 | EBV | 17 | Aspergillus | 1 |
Pseudomonas | 14 | S. aureus | 9 | Rhinovirus | 13 | Mycobacterium | 1 |
Klebsiella | 10 | Enterococcus | 8 | CMV | 11 | Undefined | 3 |
Serratia | 3 | Streptococcus | 2 | Influenza | 4 | Â | Â |
Moraxella | 2 | C. difficile | 1 | PIV | 4 | Â | Â |
Propionobacterium | 2 | Â | Â | RSV | 3 | Â | Â |
Proteus | 2 | Â | Â | HCV | 2 | Â | Â |
Stenotrophomonas | 2 | Â | Â | HSV | 2 | Â | Â |
Campylobacter | 1 | Â | Â | Adenovirus | 1 | Â | Â |
Enterobacter | 1 | Â | Â | Enterovirus | 1 | Â | Â |
Fusobacterium | 1 | Â | Â | HHV6 | 1 | Â | Â |
Haemophilus | 1 | Â | Â | HHV8 | 1 | Â | Â |
 |  |  |  | HMPV | 1 |  |  |
 |  |  |  | Norovirus | 1 |  |  |